Attenuation of embryonic cardiac arrhythmia and oxidative stress was observed with PEG SOD and NOX4 inhibitors, while CaMKII inhibitors abolished the phenotype. This evidence concerns the gene CAMK2G and chronic obstructive pulmonary disease.